Clinical trial
A Double-blind, Placebo-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder
NCT01473394 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Placebo-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- February 28, 2013
- Enrollment
- 518 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.